| Product NDC: | 67457-192 |
| Proprietary Name: | Enlon Plus |
| Non Proprietary Name: | Edrophonium Chloride and Atrophine Sulfate |
| Active Ingredient(s): | .14; 10 mg/mL; mg/mL & nbsp; Edrophonium Chloride and Atrophine Sulfate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67457-192 |
| Labeler Name: | Mylan Institutional LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019678 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19911106 |
| Package NDC: | 67457-192-05 |
| Package Description: | 10 AMPULE in 1 CARTON (67457-192-05) > 5 mL in 1 AMPULE (67457-192-00) |
| NDC Code | 67457-192-05 |
| Proprietary Name | Enlon Plus |
| Package Description | 10 AMPULE in 1 CARTON (67457-192-05) > 5 mL in 1 AMPULE (67457-192-00) |
| Product NDC | 67457-192 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Edrophonium Chloride and Atrophine Sulfate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19911106 |
| Marketing Category Name | NDA |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | ATROPINE SULFATE; EDROPHONIUM CHLORIDE |
| Strength Number | .14; 10 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |